Publikace
- Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia2016 | Lékařská fakulta v Plzni
- The Quality Control of Mesenchymal Stromal Cells by in Vitro Testing of Their Immunomodulatory Effect on Allogeneic Lymphocytes2016 | Lékařská fakulta v Plzni
- In vitro testing of immunosupressive effects of mesenchymal stromal cells on lymphocytes stimulated with alloantigens2015 | Lékařská fakulta v Plzni
- Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment2015 | Lékařská fakulta v Plzni
- Léčba chronické lymfocytární leukemie s aberací TP532015 | Lékařská fakulta v Plzni
- CD34(+) cell content in unrelated allogeneic peripheral blood stem cell grafts transported internationally. Does the inter-laboratory variability affect comparability of graft quality data?2012 | Lékařská fakulta v Plzni, Ústřední knihovna
- Changes of cytokine levels during granulocytecolony-stimulating factor stem cell mobilization in healthy donors: association with mobilization efficiency and potential predictive significance2011 | 1. lékařská fakulta, Lékařská fakulta v Plzni, Ústřední knihovna
- Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?2011 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | 1. lékařská fakulta, Lékařská fakulta v Plzni, 2. lékařská fakulta
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
Loading network view...